Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11359672 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Biological Therapy in Treating Women With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: Aldesleukin;   Biological: Sargramostim;   Biological: therapeutic autologous lymphocytes

Indicates status has not been verified in more than two years